Want to join the conversation?
Medical devices manufacturer $VAR appointed Rafael Torres as SVP, Business Development & Strategy. Torres will lead $VAR's strategic plans for growth through acquisitions, investments, and partnerships. He will report to Dow Wilson, President and CEO. Prior to joining $VAR, Torres worked as Global Head of Healthcare for GE Ventures and GE Equity.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?